Home > Boards > Stock Clubs > Market Trends and Strategies > $heff's $tation of $tocks & $olid DD

'RPTP' - (Research and Markets: Raptor Pharmaceuticals Corp.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Wrinkles Member Profile Wrinkles Member Level 
Monday, October 08, 2012 8:43:58 AM
Re: None Post # of 68964 
'RPTP' - (Research and Markets: Raptor Pharmaceuticals Corp. - Product Pipeline Review - 2012)


DUBLIN, Oct 08, 2012 (BUSINESS WIRE) -- Research and Markets
(http://www.researchandmarkets.com/research/ppn434/raptor) has announced the
addition of Global Markets Direct's new company profile "Raptor Pharmaceuticals
Corp. - Product Pipeline Review - 2012" to their offering.

This report provides data on the Raptor Pharmaceuticals Corp.'s research and
development focus. The report includes information on current developmental
pipeline, complete with latest updates, and features on discontinued and dormant
projects.

Scope:

- Raptor Pharmaceuticals Corp. - Brief Raptor Pharmaceuticals Corp. overview
including business description, key information and facts, and its locations and
subsidiaries.

- Review of current pipeline of Raptor Pharmaceuticals Corp. human therapeutic
division.

- Overview of pipeline therapeutics across various therapy areas.

- Coverage of current pipeline molecules in various stages of drug development,
including the combination treatment modalities, across the globe.

- Product profiles for late stage and clinical stage products of Raptor
Pharmaceuticals Corp. with complete description of the product's developmental
history, mechanis m of action, therapeutic class, target and major milestones.

- Recent updates of the Raptor Pharmaceuticals Corp.'s pipeline in the last
quarter.

- Key discontinued and dormant projects.

- Latest news and deals relating to the products.

Reasons to Buy:

- Evaluate Raptor Pharmaceuticals Corp.'s strategic position with total access
to detailed information on its product pipeline.

- Assess the growth potential of Raptor Pharmaceuticals Corp. in its therapy
areas of focus.

- Identify new drug targets and therapeutic classes in the Raptor
Pharmaceuticals Corp.'s R&D portfolio and develop key strategic initiatives to
reinforce pipeline in those areas.

- Exploit in-licensing opportunities by identifying windows of opportunity to
fill portfolio gaps.

- Exploit collaboration and partnership opportunities with Raptor
Pharmaceuticals Corp..

- Avoid Intellectual Property Rights related issues.

- Explore the dormant and discontinued projects of Raptor Pharmaceuticals Corp.
and identify potential opportunities in those areas.

For more information visit
http://www.researchandmarkets.com/research/ppn434/raptor

Source: Global Markets Direct

SOURCE: Research and Markets




CONTACT:
Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals




Copyright Business Wire 2012

-0-




INDUSTRY KEYWORD: Health

Pharmaceutical



Source: Comtext Market News


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist